In a subgroup analysis of the Helsinki Heart Study it was found that gemfibrozil was particularly effective in preventing heart disease in patients with high serum triglyceride concentrations, plus either low HDL-cholesterol or a high LDL/ HDL cholesterol ratio (Circulation 1992; 85: